Good Clinical Practices and Pharmacoviligance

In the changing pharmaceutical industry, companies are constantly filing drug applications for new medicines and new markets for existing medicines

This process has increased its complexity over time, involving multiple business areas and outsourcing some activities to Contract Research Organizations (CROs).

Good Clinical Practice

Pharmaceutical Industry should ensure that the requirements of Good Clinical Practice (GCP) are met, as well as the correct management and statistical processing of the associated data

Once the medicine is in the market, it is necessary to have a Pharmacovigilance system to properly manage the adverse events detected, in order to effectively detect and evaluate all potential problems. The Pharmacovigilance system should have an adequate Quality Management System and organization, as well as well-established processes to ensure compliance with Good Pharmacovigilance Practices (GVP).

Clinical Trials

Good Clinical Practices and Pharmacovigilance

Rephine’s experience in GCP and GVP includes:

Implementation of Quality Systems in medical research departments, pharmacovigilance departments and CROs.
Internal audits and audits to CROs and Pharmacovigilance Managers worldwide
Audits of clinical trials and bioequivalence studies
Validation of software related to clinical data management, statistical calculations with clinical data and pharmacovigilance data management

This process has increased its complexity over time, involving multiple business areas and outsourcing some activities to Contract Research Organizations (CROs), often located in many different countries.

Where do you Need our Help?

For GMP Auditing, Quality Assurance & Digitalisation, we’re the partner of choice for all the stakeholders we deal with.

We provide extensive GMP consulting services to help keep our clients ahead of the needs and expectations of regulators.

GMP Audit Services

GxP Consultancy

Global Audit Library

Digitalisation

Related Resources

Blog

Navigating the Evolving Landscape of Cybersecurity for Medical Devices

Cybersecurity threats to the healthcare sector have become more frequent and more severe, carrying increased potential for clinical impact. Cybersecurity incidents have rendered medical devices

Scientist, senior woman and lab with laptop, research and plants with analytics, pharmaceutical study and focus. Elderly science expert, computer and typing for data analysis for goal in laboratory

Article

Newly established 3PARL® consortium to assure global life sciences industry of consistent high standard of GMP supply chain audits

Rephine and Eurofins are acting against substandard audit practices with guarantees of the highest quality of inspection services & library reports, from raw materials to

Vaccine injection bottles with white label in a row

Blog

EU GMP Annex 1: How well has pharma adapted?

A few weeks ago, the revised EU GMP Annex 1 requirements related to the Manufacture of Sterile Medicinal Products came into force, with implications for

Case Study

2023 Medical Devices CE Mark for a MDSW (Medical Device Software)

About this Case Study The case study involved CE Mark for a new Medical Device Software. The company has developed software that is considered as

We're Exhibiting! India TUG (2000 × 1044px) (1)

Article

Rephine Exhibit at India TrackWise User Group Mumbai – Sept 1st

Rephine to Exhibit at the Upcoming India TrackWise User Group in Mumbai on September 1st We’re thrilled to announce that the Rephine India team will

Event

Rephine Golden Ticket

With Rephine, everyone’s a winner! Thank you for taking the time to visit us! As you are a Golden Ticket winner, please take the opportunity

Article

Rephine agrees Chinese distribution partnership with Trackwise

Rephine’s Chinese division signs to provide Implementation and Validation services for TrackWise EQMS solutions. Stevenage, Hertfordshire, 4 August, 2023 – Rephine, the experts in

Case Study

2023 Mock Inspection USA Market

About this Case Study The case study involved a pharmaceutical company seeking to bring a product, manufactured in Europe, into the US market for commercialisation.

Case Study

2023 Medical Devices Mock Inspection

About this Case Study The case study involved verifying GMP compliance in an IVD company to enable the commercialisation of their products in the USA.

Let's get in touch

Please get in touch. Our expert GMP audit team is only a click away, on standby to answer all your questions.

Email: [email protected]

Social:

REPHINE HQ

Stevenage, UK
+44 1763 853135

REPHINE BARCELONA S.L.U

Barcelona, Spain
+34 934 178065

REPHINE CHINA

Shanghai, China

REPHINE INDIA

Hyderabad, India

First Name

Last Name

Phone

Country

Company

Job Title

Interested In

Message

Marketing Opt In

Rephine respects your privacy. Choosing to check the box means that you agree to the Rephine Privacy Policy. You can unsubscribe at any time.